Eslam M Abbass

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Advanced Non Small Cell Lung Cancer

Silver Nanoparticles

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Eslam M Abbass, Ali Khalil Ali, Ahmed F El-Farargy, Doaa R Abdel-Haleem, Safaa S Shaban
Synthesis, toxicological and in silico evaluation of novel spiro pyrimidines against Culex pipiens L. referring to chitinase enzyme. Scientific reports 14 (1) (2024)
Eslam M Abbass, Ali Khalil Ali, Ahmed F El-Farargy, Doaa R Abdel-Haleem, Safaa S Shaban
Synthesis, toxicological and in silico evaluation of novel spiro pyrimidines against Culex pipiens L. referring to chitinase enzyme. Scientific reports 14 (1) (2024)
Eslam M Abbass, Ali Khalil Ali, Ahmed F El-Farargy, Doaa R Abdel-Haleem, Safaa S Shaban
Synthesis, toxicological and in silico evaluation of novel spiro pyrimidines against Culex pipiens L. referring to chitinase enzyme. Scientific reports 14 (1) (2024)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)
Samia M Al-Muntaser, Ahmed Ali Al-Karmalawy, Abeer M El-Naggar, Ali Khalil Ali, Nour E A Abd El-Sattar, Eslam M Abbass
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies. RSC advances 13 (18) (2023)